AOD9604

Fat LossResearch Compound

Overview

AOD9604 (Advanced Obesity Drug 9604) is a modified fragment of human growth hormone (hGH fragment 176-191). It was developed at Monash University in Australia specifically to isolate the fat-reducing effects of GH without its growth-promoting or diabetogenic properties. It received GRAS (Generally Recognized as Safe) status from the FDA as a food ingredient.

Evidence Strength

🟠

Mostly Animal Research

Primarily supported by animal model studies

🟢Human Clinical Evidence

🟡Limited Human Evidence

🟠Mostly Animal Research

🔴Preclinical / Laboratory

This information is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making any health decisions.